- Investing Ideas
- /
- Commercial Services Healthcare Sector
Commercial Services Healthcare Sector
Results
2310
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,310 companies
Ardelyx
Market Cap: US$870.9m
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$3.64
7D
-11.9%
1Y
-53.2%
Syndax Pharmaceuticals
Market Cap: US$859.6m
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$11.01
7D
-20.3%
1Y
-49.9%
Arcus Biosciences
Market Cap: US$848.1m
A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.
RCUS
US$8.53
7D
-1.0%
1Y
-47.2%
Craneware
Market Cap: UK£633.8m
Develops, licenses, and supports computer software for the healthcare industry in the United States.
CRW
UK£18.10
7D
-0.5%
1Y
-21.3%
Geron
Market Cap: US$834.4m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.26
7D
-11.9%
1Y
-67.5%
Trulieve Cannabis
Market Cap: CA$1.2b
Operates as a cannabis retailer.
TRUL
CA$6.22
7D
-2.8%
1Y
-58.9%
Gyre Therapeutics
Market Cap: US$829.6m
A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
GYRE
US$9.48
7D
1.5%
1Y
-37.8%
CareDx
Market Cap: US$822.4m
Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.
CDNA
US$15.39
7D
2.1%
1Y
39.2%
Extendicare
Market Cap: CA$1.1b
Through its subsidiaries, provides care and services for seniors in Canada.
EXE
CA$14.19
7D
0.9%
1Y
89.2%
HealthStream
Market Cap: US$820.5m
Provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.
HSTM
US$27.23
7D
-18.4%
1Y
0.3%
CorMedix
Market Cap: US$792.2m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$12.03
7D
24.7%
1Y
122.4%
Zymeworks
Market Cap: US$789.0m
A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).
ZYME
US$11.32
7D
-12.1%
1Y
22.6%
CureVac
Market Cap: US$781.3m
A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
CVAC
US$3.59
7D
5.6%
1Y
20.5%
Praxis Precision Medicines
Market Cap: US$775.9m
A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.
PRAX
US$38.06
7D
0%
1Y
-24.0%
Vir Biotechnology
Market Cap: US$774.5m
A clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.
VIR
US$5.41
7D
-11.0%
1Y
-43.4%
Spyre Therapeutics
Market Cap: US$766.1m
A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).
SYRE
US$12.86
7D
-12.3%
1Y
-63.5%
Intellia Therapeutics
Market Cap: US$754.6m
A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.
NTLA
US$8.28
7D
-4.2%
1Y
-66.7%
AMN Healthcare Services
Market Cap: US$749.1m
Provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States.
AMN
US$20.33
7D
-0.4%
1Y
-66.6%
Evolus
Market Cap: US$747.8m
A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
EOLS
US$10.09
7D
-14.5%
1Y
-23.2%
Axogen
Market Cap: US$746.3m
Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.
AXGN
US$12.59
7D
-23.6%
1Y
110.5%
SI-BONE
Market Cap: US$744.5m
A medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.
SIBN
US$18.33
7D
34.0%
1Y
18.0%
Veradigm
Market Cap: US$729.6m
A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.
MDRX
US$4.49
7D
2.0%
1Y
-42.1%
Embecta
Market Cap: US$724.9m
A medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally.
EMBC
US$13.30
7D
8.3%
1Y
-6.1%
Anavex Life Sciences
Market Cap: US$724.0m
A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.
AVXL
US$8.56
7D
-8.1%
1Y
120.6%
Healius
Market Cap: AU$1.1b
Provides specialty diagnostic services to consumer and practitioners in Australia.
HLS
AU$1.54
7D
1.7%
1Y
25.2%
Rocket Pharmaceuticals
Market Cap: US$714.4m
Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.
RCKT
US$7.04
7D
-10.4%
1Y
-69.8%
LENZ Therapeutics
Market Cap: US$713.2m
Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
LENZ
US$25.87
7D
-10.4%
1Y
68.0%
Nurix Therapeutics
Market Cap: US$709.0m
A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.
NRIX
US$9.64
7D
-13.6%
1Y
-30.9%
Cronos Group
Market Cap: CA$979.3m
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$2.78
7D
8.2%
1Y
-28.7%
Xeris Biopharma Holdings
Market Cap: US$700.6m
A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.
XERS
US$5.16
7D
15.2%
1Y
174.5%
Nuvation Bio
Market Cap: US$694.1m
A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.
NUVB
US$2.10
7D
-7.5%
1Y
-36.9%
WELL Health Technologies
Market Cap: CA$961.0m
Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.
WELL
CA$3.89
7D
-1.8%
1Y
-3.5%
ArriVent BioPharma
Market Cap: US$674.1m
A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.
AVBP
US$19.75
7D
-6.3%
1Y
9.8%
Liminatus Pharma
Market Cap: US$672.9m
Liminatus Pharma, LLC operates as a clinical-stage immuno-oncology company that develops novel cancer therapies.
LIMN
US$6.15
7D
-38.9%
1Y
-41.5%
Immunome
Market Cap: US$670.9m
A clinical-stage biotechnology company, develops targeted cancer therapies.
IMNM
US$7.71
7D
-12.9%
1Y
-50.3%
Niagen Bioscience
Market Cap: US$664.7m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$9.24
7D
22.2%
1Y
162.5%